DE FERRARI, LAURA
DE FERRARI, LAURA
100007 - Dipartimento di Medicina interna e specialità mediche
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect
2016-01-01 Chiappori, Alessandra; Folli, Chiara; Balbi, Francesco; Caci, Emanuela; Riccio, ANNA MARIA; DE FERRARI, Laura; Melioli, Giovanni; Braido, Fulvio; Canonica, Giorgio
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion.
2012-01-01 Folli, Chiara; Chiappori, Alessandra; Pellegrini, M; Garelli, V; Riccio, ANNA MARIA; DE FERRARI, Laura; Braido, Fulvio; Canonica, Giorgio
Correlated avalanches in TES noise power spectra
2009-01-01 Celasco, Edvige; Bagliani, D.; Celasco, M.; Eggenhoffner, Roberto; Gatti, Flavio; Ferrari, L.; Valle, R.
Do the current guidelines for asthma pharmacotherapy encourage over-treatment?
2020-01-01 Bagnasco, D.; Brussino, L.; Caruso, C.; Paoletti, G.; Heffler, E.; Guida, G.; Calzolari, E.; Nicola, S.; De Ferrari, L.; Passalacqua, G.; Canonica, G. W.
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD
2024-01-01 Baraldo, Simonetta; Bonato, Matteo; Cassia, Sebastiano; Casolari, Paolo; De Ferrari, Laura; Tiné, Mariaenrica; Baraldi, Federico; Bigoni, Tommaso; Riccio, Anna Maria; Braido, Fulvio; Saetta, Marina; Papi, Alberto; Contoli, Marco
Galectin-3: An early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months
2017-01-01 Riccio, ANNA MARIA; Mauri, Pierluigi; DE FERRARI, Laura; Rossi, Rossana; Di Silvestre, Dario; Benazzi, Louise; Chiappori, Alessandra; Dal Negro, Roberto Walter; Micheletto, Claudio; Canonica, Giorgio
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
2023-01-01 Bagnasco, Diego; Nicola, Stefania; Testino, Elisa; Brussino, Luisa; Pini, Laura; Caminati, Marco; Piccardo, Federica; Canevari, Rikki Frank; Melissari, Laura; Ioppi, Alessandro; Guastini, Luca; Lombardi, Carlo; Milanese, Manlio; Losa, Francesca; Robbiano, Michela; De Ferrari, Laura; Riccio, Anna Maria; Guida, Giuseppe; Bonavia, Marco; Fini, Donatella; Balbi, Francesco; Caruso, Cristiano; Paggiaro, Pierluigi; Blasi, Francesco; Heffler, Enrico; Paoletti, Giovanni; Canonica, Giorgio Walter; Senna, Gianenrico; Passalacqua, Giovanni; On Behalf Of Sani, Null
Molecular diagnosis and precision medicine in allergy management
2016-01-01 Riccio, ANNA MARIA; De Ferrari, Laura; Chiappori, Alessandra; Ledda, Sabina; Passalacqua, Giovanni; Melioli, Giovanni; Canonica, Giorgio
Molecular phenotyping and biomarker development: Are we on our way towards targeted therapy for severe asthma?
2016-01-01 DE FERRARI, Laura; Chiappori, Alessandra; Bagnasco, Diego; Riccio, ANNA MARIA; Passalacqua, Giovanni; Canonica, Giorgio
Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps
2022-01-01 Paoletti, Giovanni; Malvezzi, Luca; Riccio, Anna Maria; Descalzi, Desideria; Pirola, Francesca; Russo, Elena; De Ferrari, Laura; Racca, Francesca; Ferri, Sebastian; Messina, Maria Rita; Puggioni, Francesca; Nappi, Emanuele; Bagnasco, Diego; Canevari, Frank Rikki; Grizzi, Fabio; Mercante, Giuseppe; Spriano, Giuseppe; Canonica, Giorgio Walter; Heffler, Enrico
Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients.
2012-01-01 Riccio, ANNA MARIA; Dal Negro, Rw; Micheletto, C; DE FERRARI, Laura; Folli, Chiara; Chiappori, Alessandra; Canonica, Giorgio
Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-study
2020-01-01 Riccio, Anna Maria; Mauri, Pierluigi; De Ferrari, Laura; Rossi, Rossana; Di Silvestre, Dario; Bartezaghi, Marta; Saccheri, Fabiana; Canonica, Giorgio Walter
Proteomics of bronchial biopsies: galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients.
2014-01-01 Mauri, P; Riccio, ANNA MARIA; Rossi, R; Di Silvestre, D; Benazzi, L; DE FERRARI, Laura; Dal Negro, Rw; Holgate, St; Canonica, Giorgio
Salbutamol: how does it enter smooth muscle cells?
2012-01-01 Chiappori, Alessandra; Folli, Chiara; Riccio, ANNA MARIA; Caci, E; Descalzi, D; DE FERRARI, Laura; Ingrassia, E; Nicolini, G; Canonica, Giorgio
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life
2020-01-01 Bagnasco, Diego; Massolo, Alessandro; Bonavia, Marco; Brussino, Luisa; Bucca, Caterina; Caminati, Marco; Canonica, Giorgio Walter; Caruso, Cristiano; D'Amato, Maria; De Ferrari, Laura; Guida, Giuseppe; Heffler, Enrico; Lombardi, Carlo; Menzella, Francesco; Milanese, Manlio; Paoletti, Giovanni; Riccio, Anna Maria; Rolla, Giovanni; Senna, Gianenrico; Testino, Elisa; Passalacqua, Giovanni
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations.
2013-01-01 Bonadonna, P; Gonzalez de Olano, D.; Zanotti, R.; Riccio, ANNA MARIA; DE FERRARI, Laura; Lombardo, C.; Rogkakou, A.; Escribano, L.; Alvarez Twose, I.; Matito, A.; Vega, A.; Passalacqua, Giovanni
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect | 1-gen-2016 | Chiappori, Alessandra; Folli, Chiara; Balbi, Francesco; Caci, Emanuela; Riccio, ANNA MARIA; DE FERRARI, Laura; Melioli, Giovanni; Braido, Fulvio; Canonica, Giorgio | |
| COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. | 1-gen-2012 | Folli, Chiara; Chiappori, Alessandra; Pellegrini, M; Garelli, V; Riccio, ANNA MARIA; DE FERRARI, Laura; Braido, Fulvio; Canonica, Giorgio | |
| Correlated avalanches in TES noise power spectra | 1-gen-2009 | Celasco, Edvige; Bagliani, D.; Celasco, M.; Eggenhoffner, Roberto; Gatti, Flavio; Ferrari, L.; Valle, R. | |
| Do the current guidelines for asthma pharmacotherapy encourage over-treatment? | 1-gen-2020 | Bagnasco, D.; Brussino, L.; Caruso, C.; Paoletti, G.; Heffler, E.; Guida, G.; Calzolari, E.; Nicola, S.; De Ferrari, L.; Passalacqua, G.; Canonica, G. W. | |
| Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD | 1-gen-2024 | Baraldo, Simonetta; Bonato, Matteo; Cassia, Sebastiano; Casolari, Paolo; De Ferrari, Laura; Tiné, Mariaenrica; Baraldi, Federico; Bigoni, Tommaso; Riccio, Anna Maria; Braido, Fulvio; Saetta, Marina; Papi, Alberto; Contoli, Marco | |
| Galectin-3: An early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months | 1-gen-2017 | Riccio, ANNA MARIA; Mauri, Pierluigi; DE FERRARI, Laura; Rossi, Rossana; Di Silvestre, Dario; Benazzi, Louise; Chiappori, Alessandra; Dal Negro, Roberto Walter; Micheletto, Claudio; Canonica, Giorgio | |
| Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders | 1-gen-2023 | Bagnasco, Diego; Nicola, Stefania; Testino, Elisa; Brussino, Luisa; Pini, Laura; Caminati, Marco; Piccardo, Federica; Canevari, Rikki Frank; Melissari, Laura; Ioppi, Alessandro; Guastini, Luca; Lombardi, Carlo; Milanese, Manlio; Losa, Francesca; Robbiano, Michela; De Ferrari, Laura; Riccio, Anna Maria; Guida, Giuseppe; Bonavia, Marco; Fini, Donatella; Balbi, Francesco; Caruso, Cristiano; Paggiaro, Pierluigi; Blasi, Francesco; Heffler, Enrico; Paoletti, Giovanni; Canonica, Giorgio Walter; Senna, Gianenrico; Passalacqua, Giovanni; On Behalf Of Sani, Null | |
| Molecular diagnosis and precision medicine in allergy management | 1-gen-2016 | Riccio, ANNA MARIA; De Ferrari, Laura; Chiappori, Alessandra; Ledda, Sabina; Passalacqua, Giovanni; Melioli, Giovanni; Canonica, Giorgio | |
| Molecular phenotyping and biomarker development: Are we on our way towards targeted therapy for severe asthma? | 1-gen-2016 | DE FERRARI, Laura; Chiappori, Alessandra; Bagnasco, Diego; Riccio, ANNA MARIA; Passalacqua, Giovanni; Canonica, Giorgio | |
| Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps | 1-gen-2022 | Paoletti, Giovanni; Malvezzi, Luca; Riccio, Anna Maria; Descalzi, Desideria; Pirola, Francesca; Russo, Elena; De Ferrari, Laura; Racca, Francesca; Ferri, Sebastian; Messina, Maria Rita; Puggioni, Francesca; Nappi, Emanuele; Bagnasco, Diego; Canevari, Frank Rikki; Grizzi, Fabio; Mercante, Giuseppe; Spriano, Giuseppe; Canonica, Giorgio Walter; Heffler, Enrico | |
| Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients. | 1-gen-2012 | Riccio, ANNA MARIA; Dal Negro, Rw; Micheletto, C; DE FERRARI, Laura; Folli, Chiara; Chiappori, Alessandra; Canonica, Giorgio | |
| Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-study | 1-gen-2020 | Riccio, Anna Maria; Mauri, Pierluigi; De Ferrari, Laura; Rossi, Rossana; Di Silvestre, Dario; Bartezaghi, Marta; Saccheri, Fabiana; Canonica, Giorgio Walter | |
| Proteomics of bronchial biopsies: galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients. | 1-gen-2014 | Mauri, P; Riccio, ANNA MARIA; Rossi, R; Di Silvestre, D; Benazzi, L; DE FERRARI, Laura; Dal Negro, Rw; Holgate, St; Canonica, Giorgio | |
| Salbutamol: how does it enter smooth muscle cells? | 1-gen-2012 | Chiappori, Alessandra; Folli, Chiara; Riccio, ANNA MARIA; Caci, E; Descalzi, D; DE FERRARI, Laura; Ingrassia, E; Nicolini, G; Canonica, Giorgio | |
| The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life | 1-gen-2020 | Bagnasco, Diego; Massolo, Alessandro; Bonavia, Marco; Brussino, Luisa; Bucca, Caterina; Caminati, Marco; Canonica, Giorgio Walter; Caruso, Cristiano; D'Amato, Maria; De Ferrari, Laura; Guida, Giuseppe; Heffler, Enrico; Lombardi, Carlo; Menzella, Francesco; Milanese, Manlio; Paoletti, Giovanni; Riccio, Anna Maria; Rolla, Giovanni; Senna, Gianenrico; Testino, Elisa; Passalacqua, Giovanni | |
| Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations. | 1-gen-2013 | Bonadonna, P; Gonzalez de Olano, D.; Zanotti, R.; Riccio, ANNA MARIA; DE FERRARI, Laura; Lombardo, C.; Rogkakou, A.; Escribano, L.; Alvarez Twose, I.; Matito, A.; Vega, A.; Passalacqua, Giovanni |